| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 27.214 | 168.727 | 211.334 | 260.533 | 278.890 | 319.353 | 304.809 | 0 |
| Total Income - EUR | - | - | 27.214 | 168.753 | 211.335 | 260.778 | 279.196 | 321.677 | 377.126 | 3.980 |
| Total Expenses - EUR | - | - | 26.522 | 141.065 | 184.917 | 233.238 | 253.445 | 290.546 | 291.506 | 8.857 |
| Gross Profit/Loss - EUR | - | - | 692 | 27.688 | 26.418 | 27.540 | 25.751 | 31.130 | 85.620 | -4.877 |
| Net Profit/Loss - EUR | - | - | 405 | 25.996 | 24.298 | 25.715 | 23.756 | 28.612 | 82.966 | -4.925 |
| Employees | - | - | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 1 |
Check the financial reports for the company - Alania Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.955 | 1.577 | 3.748 | 24.905 | 17.704 | 7.573 | 8.072 | 87.844 |
| Current Assets | - | - | 18.381 | 72.846 | 71.633 | 106.142 | 106.496 | 110.121 | 124.929 | 125 |
| Inventories | - | - | 2.005 | 14.918 | 19.170 | 32.933 | 36.412 | 41.561 | 0 | 0 |
| Receivables | - | - | 13.798 | 37.842 | 36.268 | 52.155 | 61.224 | 63.289 | 120.702 | 122 |
| Cash | - | - | 2.577 | 20.086 | 16.196 | 21.054 | 8.859 | 5.271 | 4.228 | 4 |
| Shareholders Funds | - | - | 451 | 26.439 | 28.154 | 40.779 | 41.809 | 28.778 | 93.553 | 86.794 |
| Social Capital | - | - | 46 | 45 | 44 | 43 | 42 | 43 | 202 | 201 |
| Debts | - | - | 19.884 | 48.131 | 47.432 | 90.374 | 82.752 | 89.359 | 39.594 | 1.175 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Alania Pharm S.r.l.